DocSym
β
Searchsearch
Search
(M80.4) Drug-induced osteoporosis with pathological fracture
More details coming soon
1 643 865 in individuals diagnosis drug-induced osteoporosis with pathological fracture confirmed
39 170 deaths with diagnosis drug-induced osteoporosis with pathological fracture
2% mortality rate associated with the disease drug-induced osteoporosis with pathological fracture
Diagnosis drug-induced osteoporosis with pathological fracture is diagnosed Women are 68.17% more likely than Men
261 629
Men receive the diagnosis drug-induced osteoporosis with pathological fracture
13 318 (5.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 382 236
Women receive the diagnosis drug-induced osteoporosis with pathological fracture
25 852 (1.9 %)Died from this diagnosis.
Risk Group for the Disease drug-induced osteoporosis with pathological fracture - Men and Women aged 80-84
In Men diagnosis is most often set at age 0-19, 25-95+
Less common in men the disease occurs at Age 20-24in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features drug-induced osteoporosis with pathological fracture
Absence or low individual and public risk
Drug-induced osteoporosis with pathological fracture - what does this mean
Drug-induced osteoporosis with pathological fracture occurs when the use of certain prescription medications, such as glucocorticoids, leads to a decrease in bone mineral density which weakens the bones and increases the risk of fracture. the pathological fracture is a fracture that occurs due to the weakened bone structure, and is typically more severe than a normal fracture.
What happens during the disease - drug-induced osteoporosis with pathological fracture
Drug-induced osteoporosis with pathological fracture is a condition in which long-term use of certain medications, such as corticosteroids, anticonvulsants, and some chemotherapeutic agents, leads to a decrease in bone density and an increased risk of fracture. this decrease in bone density can lead to a weakened bone structure, making it more vulnerable to fractures, even from minor trauma. additionally, the decrease in bone density can cause a decrease in bone strength, leading to an increased risk of spontaneous fractures.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete medical history and physical examination
- Blood tests to check calcium, phosphorus, and alkaline phosphatase levels
- Bone density scan (DXA)
- X-rays of the affected area
- CT scan or MRI of the affected area
- Bone biopsy
- Kidney function tests
- Thyroid function tests
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of further fractures and improve bone density.
- Prescribe medications to reduce bone breakdown and increase bone mineral density.
- Administer calcium, vitamin D and other supplements to enhance bone health.
- Provide lifestyle counseling to increase physical activity and reduce risk factors such as smoking.
- Perform imaging studies to assess bone density and detect fractures.
- Refer to physical therapy for exercises to strengthen bones.
- Refer to a specialist for further evaluation and management.
23 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Drug-induced osteoporosis with pathological fracture - Prevention
The best way to prevent drug-induced osteoporosis with pathological fracture is to practice healthy lifestyle habits such as eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, taking medications that are known to increase the risk of osteoporosis should be done under the guidance of a healthcare provider.